Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY® (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
AJOVY is indicated for: the preventive treatment of migraine in adults, and the preventive treatment of episodic migraine in pediatric patients who are 6 to 17 years of age and who weigh 45 kg or more.
- generic_name
- fremanezumab-vfrm
- product_names
- fremanezumab-vfrm
- ndc
- 51759-204, 51759-204-10, 51759-204-11, 51759-202, 51759-202-10, 51759-202-11, 51759-202-22
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en